相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
Irene Marini et al.
HAEMATOLOGICA (2021)
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia
Mathilde Roumier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
Liang Wang et al.
PLATELETS (2020)
Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis
Teeraya Puavilai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
Adrian C. Newland et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group
Maria L. Avila et al.
HAEMATOLOGICA (2020)
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
Sue Pavord et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study
Eirik Tjonnfjord et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Management of major bleeds in patients with immune thrombocytopenia
Siraj Mithoowani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Real-world evidence on clinical outcomes in immune thrombocytopenia treated with thrombopoietin receptor agonists
Anna Forsythe et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
Leah J. McGrath et al.
CLINICAL EPIDEMIOLOGY (2020)
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia
Ralph Boccia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan
Takaaki Hato et al.
BLOOD ADVANCES (2020)
Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center
Jose Carlos Jaime-Perez et al.
ANNALS OF HEMATOLOGY (2020)
Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: A systematic review and meta-analysis
S. N. Amini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both
Marcel Levi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study
Jie Ma et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
Tadeusz Robak et al.
BLOOD ADVANCES (2020)
Second-line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records
Lincy S. Lal et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia
Hanny Al-Samkari et al.
BLOOD ADVANCES (2020)
The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia
Yan-ming Wang et al.
HEMATOLOGY (2020)
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia
Richard Vollenberg et al.
HAEMATOLOGICA (2019)
Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis
Irene Marini et al.
HAMOSTASEOLOGIE (2019)
Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia
Kasper Adelborg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study
Anna Kwiatkowska et al.
MEDICINA-LITHUANIA (2019)
The efficacy and safety of low-dose rituximab in immune thrombocytopenia: a systematic review and meta-analysis
Yunjie Li et al.
PLATELETS (2019)
A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia
Hai Zhou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
William A. Hammond et al.
MAYO CLINIC PROCEEDINGS (2019)
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
James B. Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance
Marie A. Hollenhorst et al.
BLOOD ADVANCES (2019)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD ADVANCES (2019)
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
James Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura
Joan D. Beckman et al.
AMERICAN JOURNAL OF THERAPEUTICS (2018)
Splenectomy for immune thrombocytopenia: down but not out
Shruti Chaturvedi et al.
BLOOD (2018)
Fostamatinib for persistent/chronic adult immune thrombocytopenia
Adrian Newland et al.
IMMUNOTHERAPY (2018)
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
M. -L. Piel-Julian et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Megakaryocyte apoptosis in immune thrombocytopenia
John R. Vrbensky et al.
PLATELETS (2018)
Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
Hanny Al-Samkari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia
Hanny Al-Samkari et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
Wojciech Jurczak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia
Guosheng Li et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, OGHO, SGH, GPOH, and DGTI
Axel Matzdorff et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis
Jia Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets
M. Edward Quach et al.
BLOOD (2018)
Response of first line treatment with corticosteroids in a population-based cohort of adults with primary immune thrombocytopenia
Henrik Frederiksen et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
Lili Tao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea
Ji Yun Lee et al.
THROMBOSIS RESEARCH (2017)
Successful treatment of bleeding with tranexamic acid in a series of 12 patients with immune thrombocytopenia
Beate Mayer et al.
VOX SANGUINIS (2017)
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study
Raymond S. M. Wong et al.
BLOOD (2017)
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry
Donald M. Arnold et al.
BLOOD ADVANCES (2017)
Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases
Zeping Zhou et al.
AUTOIMMUNITY (2016)
Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study
Mette Norgaard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Platelet destruction in immune thrombocytopenia Understanding the mechanisms
Tamam Bakchoul et al.
HAMOSTASEOLOGIE (2016)
Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study
Young Hoon Park et al.
ACTA HAEMATOLOGICA (2016)
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years
Francesca Palandri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
Ann Janssens et al.
ANNALS OF HEMATOLOGY (2016)
Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
Indraraj Umesh Doobaree et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes
Kai Ding et al.
ONCOLOGY LETTERS (2016)
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
Lamiae Grimaldi-Bensouda et al.
HAEMATOLOGICA (2016)
High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis
Siraj Mithoowani et al.
LANCET HAEMATOLOGY (2016)
Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies
Nora P. Goette et al.
PLOS ONE (2016)
CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia
Jihua Qiu et al.
SCIENTIFIC REPORTS (2016)
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Tomas Jose Gonzalez-Lopez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Fatigue in immune thrombocytopenia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
Muna Iraqi et al.
HAEMATOLOGICA (2015)
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
C. Neunert et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia
Hai Zhou et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
June Li et al.
NATURE COMMUNICATIONS (2015)
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
Muna Iraqi et al.
HAEMATOLOGICA (2015)
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis
Shaan Chugh et al.
LANCET HAEMATOLOGY (2015)
Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia
Zhenhua Zhao et al.
PLOS ONE (2015)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Guillaume Moulis et al.
BLOOD (2014)
Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study
Henrik Frederiksen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Foxp3 methylation status in children with primary immune thrombocytopenia
Zhenping Chen et al.
HUMAN IMMUNOLOGY (2014)
Long-Term Outcomes of Laparoscopic Splenectomy Versus Open Splenectomy for Idiopathic Thrombocytopenic Purpura
Yikun Qu et al.
INTERNATIONAL SURGERY (2014)
T cell immune abnormalities in immune thrombocytopenia
Xuebin Ji et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study
J. Peng et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Safety and Efficacy of Gammaplex® in Idiopathic Thrombocytopenic Purpura (ClinicalTrials.gov-NCT00504075)
Clive H. Dash et al.
PLOS ONE (2014)
Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia
Maria Teresa Alvarez Roman et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
Cellular immune dysfunction in immune thrombocytopenia (ITP)
Christopher G. J. McKenzie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Stromal-derived factor-1 gene variations in pediatric patients with primary immune thrombocytopenia
Fan-Chen Ku et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia
Jose R. Gonzalez-Porras et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials
Francesco Rodeghiero et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
Pathophysiology and management of primary immune thrombocytopenia
Hirokazu Kashiwagi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
B-Cell Depletion in Immune Thrombocytopenia
Bertrand Godeau
SEMINARS IN HEMATOLOGY (2013)
Glycosylation of autoantibodies: Insights into the mechanisms of immune thrombocytopenia
Tamam Bakchoul et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin
Jeannine Winkler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Ibα-14-3-3ζ] association
Dianne E. van der Wal et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
Roberto Stasi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
ITP in Children
John A. D’Orazio et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia
Y. Tomiyama et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases A historical review
Paul Imbach
SWISS MEDICAL WEEKLY (2012)
Spotlight on Eltrombopag in Treatment-Refractory Chronic Primary Immune Thrombocytopenia
Karly P. Garnock-Jones
BIODRUGS (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Marianne T. Severinsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Fatigue in adult patients with primary immune thrombocytopenia
Julia L. Newton et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia
Lei Yang et al.
BLOOD (2010)
The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials
Yuan-Han Qin et al.
BLOOD COAGULATION & FIBRINOLYSIS (2010)
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
T. B. Gernsheimer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Complement activation on platelets: Implications for vascular inflammation and thrombosis
Ellinor I. Peerschke et al.
MOLECULAR IMMUNOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FATIGUE AS MARKER OF THROMBOCYTOPENIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
Julie Blatt et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2010)
Long-term management of chronic immune thrombocytopenic purpura in adults
Javier Palau et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2010)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk et al.
BLOOD (2009)
TPO-mimetics and myelofibrosis? A reticulin question!
Michele P. Lambert
BLOOD (2009)
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
David J. Kuter et al.
BLOOD (2009)
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database
W. Marieke Schoonen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
The Immune Thrombocytopenia Syndrome: A Disorder of Diverse Pathogenesis and Clinical Presentation
Douglas B. Cines et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies
C. Zhao et al.
HAEMATOLOGICA (2008)
Intravenous immunoglobulin: Adverse reactions and management
Francisco A. Bonilla
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP
Lemke K. Page et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)
Michael D. Tarantino et al.
BLOOD (2007)
Programmed anuclear cell death delimits platelet life span
Kylie D. Mason et al.
CELL (2007)
Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia
O. Meyer et al.
PEDIATRIC BLOOD & CANCER (2006)
Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies
Michelle Lee Webster et al.
BLOOD (2006)
Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura
F Zhang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Childhood ITP:: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
P Imbach et al.
PEDIATRIC BLOOD & CANCER (2006)
Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: A systematic review and meta-analysis of randomized controlled trials
CE Beck et al.
JOURNAL OF PEDIATRICS (2005)
Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura
AR Gaines
BLOOD (2005)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
R McMillan et al.
BLOOD (2004)
Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura
EJ Houwerzijl et al.
BLOOD (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients
AJ Neylon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro
M Chang et al.
BLOOD (2003)
Mechanism of action of IVIG and anti-D in ITP
AH Lazarus et al.
TRANSFUSION AND APHERESIS SCIENCE (2003)
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group
T Kuhne et al.
JOURNAL OF PEDIATRICS (2003)
The use of recombinant factor VIIA in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage
DP Waddington et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage
GT Gerotziafas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRγ chain
B Nieswandt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
YC Cohen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
